Payment overview · 2025
General Payments
$145.32
1 reported records · 1 companies
Healthcare provider profile · identity verified
Michael Edwin Sheedy, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · CHATHAM, IL · NPI 1790758894
Verified facts
What the public records show
CMS Open Payments records show Michael Edwin Sheedy, M.D. received $145.32 in general payments during 2025 across 1 reported records.
Amgen Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $145.32 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $145.32 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| KRYSTEXXA Normalized: krystexxa |
Biological | Amgen Inc. | $145.32 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 490 | 121 |
| Lisinopril | Lisinopril | 465 | 122 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 386 | 114 |
| Amlodipine Besylate | Amlodipine Besylate | 382 | 105 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 331 | 65 |
| Losartan Potassium | Losartan Potassium | 330 | 95 |
| Metformin Hcl | Metformin Hcl | 327 | 86 |
| Metoprolol Succinate | Metoprolol Succinate | 280 | 80 |
| Pravastatin Sodium | Pravastatin Sodium | 274 | 74 |
| Levothyroxine Sodium | Levothyroxine Sodium | 255 | 58 |
| Omeprazole | Omeprazole | 246 | 65 |
| Tamsulosin Hcl | Tamsulosin Hcl | 196 | 46 |
| Tramadol Hcl | Tramadol Hcl | 196 | 56 |
| Simvastatin | Simvastatin | 190 | 48 |
| Furosemide | Furosemide | 189 | 48 |
| Alprazolam | Alprazolam | 170 | 48 |
| Carvedilol | Carvedilol | 170 | 37 |
| Allopurinol | Allopurinol | 167 | 44 |
| Eliquis | Apixaban | 167 | 30 |
| Gabapentin | Gabapentin | 167 | 42 |
| Hydrochlorothiazide | Hydrochlorothiazide | 166 | 48 |
| Metoprolol Tartrate | Metoprolol Tartrate | 158 | 37 |
| Pantoprazole Sodium | Pantoprazole Sodium | 157 | 51 |
| Famotidine | Famotidine | 149 | 40 |
| Trazodone Hcl | Trazodone Hcl | 147 | 28 |
| Sertraline Hcl | Sertraline Hcl | 133 | 36 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 116 | 22 |
| Warfarin Sodium | Warfarin Sodium | 114 | 17 |
| Montelukast Sodium | Montelukast Sodium | 108 | 28 |
| Escitalopram Oxalate | Escitalopram Oxalate | 107 | 24 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 105 | 24 |
| Jardiance | Empagliflozin | 102 | 26 |
| Potassium Chloride | Potassium Chloride | 98 | 24 |
| Fluoxetine Hcl | Fluoxetine Hcl | 95 | 20 |
| Clopidogrel | Clopidogrel Bisulfate | 90 | 20 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 87 | 31 |
| Citalopram Hbr | Citalopram Hydrobromide | 85 | 19 |
| Ezetimibe | Ezetimibe | 78 | 21 |
| Clonazepam | Clonazepam | 76 | 28 |
| Alendronate Sodium | Alendronate Sodium | 73 | 20 |
| Spironolactone | Spironolactone | 69 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 65 | 13 |
| Lorazepam | Lorazepam | 63 | 22 |
| Glipizide Er | Glipizide | 62 | 19 |
| Doxazosin Mesylate | Doxazosin Mesylate | 61 | 15 |
| Ozempic | Semaglutide | 60 | 11 |
| Duloxetine Hcl | Duloxetine Hcl | 58 | 12 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 57 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 57 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 56 | 18 |
| Lovastatin | Lovastatin | 56 | 14 |
| Pregabalin | Pregabalin | 51 | 15 |
| Cephalexin | Cephalexin | 50 | 38 |
| Buspirone Hcl | Buspirone Hcl | 49 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 48 | 12 |
| Fenofibrate | Fenofibrate,micronized | 47 | 12 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 44 | 34 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 44 | 18 |
| Levetiracetam | Levetiracetam | 44 | suppressed |
| Prednisone | Prednisone | 44 | 34 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 42 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 42 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 41 | suppressed |
| Primidone | Primidone | 40 | suppressed |
| Rybelsus | Semaglutide | 40 | suppressed |
| Chlorthalidone | Chlorthalidone | 37 | suppressed |
| Fenofibrate | Fenofibrate | 37 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 36 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 35 | 11 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 35 | suppressed |
| Mirtazapine | Mirtazapine | 34 | suppressed |
| Atenolol | Atenolol | 32 | suppressed |
| Fluocinonide | Fluocinonide | 31 | 16 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 30 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 29 | 18 |
| Enalapril Maleate | Enalapril Maleate | 29 | suppressed |
| Celecoxib | Celecoxib | 28 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 28 | suppressed |
| Fentanyl | Fentanyl | 28 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 28 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 28 | 12 |
| Temazepam | Temazepam | 28 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 27 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 26 | suppressed |
| Meloxicam | Meloxicam | 26 | 13 |
| Solifenacin Succinate | Solifenacin Succinate | 26 | suppressed |
| Trulicity | Dulaglutide | 26 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 25 | suppressed |
| Myrbetriq | Mirabegron | 25 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 24 | suppressed |
| Ramipril | Ramipril | 24 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 24 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 23 | suppressed |
| Bupropion Xl | Bupropion Hcl | 22 | suppressed |
| Lansoprazole | Lansoprazole | 22 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 22 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 21 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 21 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Mesalamine | Mesalamine | 19 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 19 | suppressed |
| Fluconazole | Fluconazole | 18 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 17 | suppressed |
| Torsemide | Torsemide | 17 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 16 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 16 | suppressed |
| Clotrimazole | Clotrimazole | 15 | suppressed |
| Finasteride | Finasteride | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 14 | 11 |
| Estradiol | Estradiol | 14 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | 11 |
| Praluent Pen | Alirocumab | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Tiadylt Er | Diltiazem Hcl | 14 | suppressed |
| Baclofen | Baclofen | 13 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 13 | suppressed |
| Digoxin | Digoxin | 13 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 13 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 12 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 12 | suppressed |
| Klor-Con M20 | Potassium Chloride | 12 | suppressed |
| Linzess | Linaclotide | 12 | suppressed |
| Memantine Hcl | Memantine Hcl | 12 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Amoxicillin | Amoxicillin | 11 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 11 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 11 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 11 | 11 |
| Prazosin Hcl | Prazosin Hcl | 11 | suppressed |
| Ranolazine Er | Ranolazine | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
| Sulfasalazine | Sulfasalazine | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $145.32 · 1 records | Amgen Inc. | KRYSTEXXA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error